1. The stated business model

Larexod has been designated as an affiliate publishing website. In an affiliate model, a publisher may receive a commission when a reader follows a clearly identified partner link and later completes a qualifying action under that partner's programme terms.

2. Current status: no active affiliate links

No affiliate network, partner, tracking domain or destination URL was supplied for this production build. The current version therefore contains no active commission-generating affiliate links. The disclosure exists because affiliate is the declared business model and because transparency should be established before monetisation is added.

3. No hidden destination

The site does not use cloaking, crawler-specific destinations, hidden redirects, source-dependent redirects, delayed redirects or invisible frames to conceal where a link goes. If affiliate links are added in future, the user and search engine should see the same page and the destination should not be misrepresented.

4. How commissions may work in future

If an affiliate programme is activated, the commercial partner may attribute a referral using a link parameter, cookie, click identifier, server-to-server event or another disclosed mechanism. The exact method must be documented only after a real partner and implementation exist.

5. Effect on price

No claim is made that affiliate commissions will or will not change the user's price because no partner arrangement has been supplied. Any future statement about price must reflect the actual programme terms.

6. Editorial independence

Educational content should be written because it helps explain the topic, not because a specific product pays a higher commission. Health information should not exaggerate benefits, minimise risks or imply guaranteed results to improve commercial performance.

7. Selection methodology

No product-ranking or recommendation methodology is currently active because there are no active affiliate products. If recommendation content is introduced, selection criteria should be published and should distinguish factual product information from editorial judgement.

8. Health-related commercial content

Diabetes is a health topic. Affiliate relationships must never be used to present an unverified product as a cure, replace prescribed treatment, encourage unsafe medication changes or create false urgency. Any product or service discussion should respect applicable advertising, consumer-protection and health-information standards.

9. Partner responsibility

A future merchant or affiliate network would be responsible for its own website, products, pricing, fulfilment, warranties, data processing and terms. Larexod should not impersonate a partner or promise performance that the partner has not actually guaranteed.

10. Identification of links

If affiliate links are later added, they should be recognisable in context and accompanied by clear disclosure where a reader could reasonably make a commercial decision. Disclosure should not be buried only in this legal page.

11. Privacy and tracking

Affiliate tracking can involve personal data or device identifiers. Before enabling it, the operator should update the Privacy Policy and Cookie Policy to match the real tracking technology and assess applicable Kenya data-protection requirements.

12. Changes

This disclosure should be updated when a real network or partner is added, when tracking changes, or when monetisation moves away from affiliate publishing.

13. Contact

Questions about funding or affiliate transparency can be sent to [email protected].

14. What counts as an affiliate link

An affiliate link is a link or referral mechanism that can identify Larexod as the source of a visit or qualifying action so that compensation may be credited under a partner programme. A normal citation, internal navigation link or plain reference to a brand is not automatically an affiliate link.

15. Point-of-decision disclosure

If monetised links are introduced, readers should not have to find this page before understanding the commercial relationship. A short, clear disclosure should appear close to recommendation or comparison content where the commercial relationship could influence a user's decision.

16. No disguised buttons or fake editorial actions

Commercial links should not be disguised as site-navigation controls, fake download buttons, medical test results or system warnings. Button text should accurately describe the action a reader is taking.

17. Reviews and comparisons

The site currently has no product review or ranking system. If reviews are added, criteria should be defined in advance and should include relevant limitations. Payment, commission rate or access to a partner should not be represented as evidence that a product is medically effective.

18. Evidence and health claims

Affiliate compensation does not lower the evidentiary standard for health content. Statements about diagnosis, treatment, prevention, devices or supplements should be supported appropriately and should not overstate what a product can do. Where professional advice is required, the site should say so plainly.

19. Medicines and regulated products

This website should not use affiliate incentives to encourage unsafe self-medication, replacement of prescribed insulin or other medicines, or purchase of unverified products presented as cures. If a future programme involves regulated health products, the operator should obtain specific compliance review before publication.

20. Partner due diligence

Before activating a partner, the operator should confirm the merchant identity, destination domain, programme terms, tracking mechanism, privacy implications, claims permitted by the programme and whether the products can lawfully be promoted to the intended audience.

21. Data minimisation

Affiliate attribution should be configured to collect no more personal data than necessary for the legitimate commercial purpose. The site should avoid adding unrelated trackers merely because they are technically available through a network dashboard.

22. Cookie and consent alignment

If affiliate tracking sets non-essential cookies or uses advertising identifiers, those technologies must be reflected in the Cookie Policy and any required consent mechanism. The legal disclosure, browser behaviour and technical configuration should agree with one another.

23. Sponsored content

Affiliate links and paid sponsorship are different commercial arrangements. If a future article is paid for, supplied by a sponsor or subject to material editorial control by another party, that relationship should be disclosed separately rather than being hidden under a generic affiliate statement.

24. Gifts, samples and free access

If a product, service, device or subscription is provided free or at a discount for review, that material connection should be disclosed where it could affect how readers evaluate the content.

25. Corrections and discontinued relationships

If a partner relationship ends, broken or obsolete affiliate links should be removed or converted to ordinary references as appropriate. Disclosures should not continue to claim an active relationship that no longer exists.

26. Reader questions

Readers may ask whether a particular link or article is commercial by contacting [email protected]. The operator should be able to explain the relationship in plain language and should not require a reader to infer it from tracking parameters.